drugset / Trial / NCT07036159
A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of reduced antigen doses and alternative vaccination regimes for RTS,S/AS01E in healthy children aged 5-60 months in a malaria-endemic area.
Timeline
- Start
- 2025-08-06
- Primary completion
- 2027-04-23
- Completion
- 2027-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RTS,S/AS01E | Vaccine | — | Intramuscular |